TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30952794

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg twice daily
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 29150738

Group type: EXPERIMENTAL
Intervention: Parent-mediated intervention for young children with autism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autism Family Experience Questionnaire (AFEQ)
Number of subjects: 0
Study: 27213493

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 84
Study: 24333490

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 1264
Study: 22708885

Group type: EXPERIMENTAL
Intervention: Self-distanced perspective
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-immersed perspective
Number of subjects: 0
Study: 20178617

Group type: EXPERIMENTAL
Intervention: Intensive Individual Intervention (III)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Intensive Group Intervention (IGI)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Minimal Intervention (MI)
Number of subjects: 287
Study: 18401214

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy
Number of subjects: 610
Study: 16095054

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 13
Study: 12074225

Group type: EXPERIMENTAL
Intervention: Systematic methods of evidence-based medicine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High levels of quality of evidence
Number of subjects: 45
Study: 10024849

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery (ER) trial - cooling with a high velocity fan during recovery periods
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal Recovery (NR) trial - no cooling during recovery periods
Number of subjects: 12
Study: 7479624

Group type: EXPERIMENTAL
Intervention: Social marketing theory (SMT) recruitment materials in Treatment Hall
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Usual Care recruitment materials in Control Hall
Number of subjects: 1433
Study: 2265248

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Purified factor IX concentrate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both concentrates
Number of subjects: 11
Study: 7033426

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg intramuscularly each week)
Number of subjects: 33
Study: 31525220

Group type: EXPERIMENTAL
Intervention: Customized avatar body
Number of subjects: 2

Group type: COMPARATOR
Intervention: Abstract cube that responded to their movements
Number of subjects: 2

Group type: COMPARATOR
Intervention: Artificial 'pseudosynchrony' dataset
Number of subjects: 2
Study: 27687519

Group type: EXPERIMENTAL
Intervention: Ancient grain bread
Number of subjects: 45

Group type: COMPARATOR
Intervention: Modern grain bread
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ancient grain bread (Verna variety)
Number of subjects: 45
Study: 23907693

Group type: EXPERIMENTAL
Intervention: Linear lesions (LL)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation (PVI)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PVI + LL
Number of subjects: 28
Study: 23522799

Group type: EXPERIMENTAL
Intervention: 1.8 g/d n‐3 (1.08g eicosapentoaenoic acid + 0.72 g docosahexaenoic acid)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 40 g/d walnut
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2.0 g/d conjugated linoleic acid (CLA)
Number of subjects: 45
Study: 20360492

Group type: EXPERIMENTAL
Intervention: Remifentanil and propofol (R&P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Morphine and midazolam (M&M)
Number of subjects: 40
Study: 19212858

Group type: EXPERIMENTAL
Intervention: Collagen hydrolysate (CH) 10 g daily for 6 months
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 250
Study: 18681246

Group type: EXPERIMENTAL
Intervention: Three-year randomized control trial of different models of service provision
Number of subjects: 11
Study: 16124971

Group type: EXPERIMENTAL
Intervention: Simplex AF cement (high-viscosity)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Simplex P cement (low/medium viscosity)
Number of subjects: 39
Study: 11880904

Group type: EXPERIMENTAL
Intervention: Subvastus approach
Number of subjects: 19

Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 19
Study: 11864500

Group type: EXPERIMENTAL
Intervention: Type I inactivated vaccine against HFRS
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 401
Study: 8668427

Group type: EXPERIMENTAL
Intervention: Reproductive method of estimation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Verbal method of estimation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Complex physical tasks (e.g., ball throws)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Pace of task performance (slow vs rapid)
Number of subjects: 92
Study: 2774039

Group type: EXPERIMENTAL
Intervention: Deep cauterization of the punctum and vertical canaliculus
Number of subjects: 23

Group type: COMPARATOR
Intervention: Superficial cauterization of the punctum only
Number of subjects: 23
Study: 362893

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (12 mg/kg/day for 10 days)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sulfamethoxazole (50 mg/kg/day for 10 days)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sulfamethoxazole
Number of subjects: 118
Study: 30626906

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40IU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 28480382

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation
Number of subjects: 24
Study: 25548103

Group type: EXPERIMENTAL
Intervention: Capillary blood sampling using HemoCue WBC DIFF system
Number of subjects: 73

Group type: COMPARATOR
Intervention: Venous blood sampling
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Capillary blood sampling
Number of subjects: 73
Study: 23301057

Group type: EXPERIMENTAL
Intervention: Letrozole and Everolimus
Number of subjects: 81

Group type: COMPARATOR
Intervention: Letrozole and Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Everolimus alone (pre-surgical)
Number of subjects: 81
Study: 21052022

Group type: EXPERIMENTAL
Intervention: Beta-blocker or diuretic monotherapy
Number of subjects: 5152

Group type: EXPERIMENTAL
Intervention: Beta-blocker or diuretic-based treatment
Number of subjects: 5152

Group type: COMPARATOR
Intervention: Diltiazem-based treatment
Number of subjects: 5152
Study: 19319994

Group type: EXPERIMENTAL
Intervention: Antidepressant medication or interpersonal therapy (RCT participants, n=105)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Clinic patients (n=151)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: RCT participants (n=105)
Number of subjects: 256
Study: 17401733

Group type: EXPERIMENTAL
Intervention: Individualized amino acid mixture plus Remeron
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo plus Remeron
Number of subjects: 40
Study: 15554569

Group type: EXPERIMENTAL
Intervention: Manualized group-based intervention (weekly 90-min sessions over 6 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Single educational session (control condition)
Number of subjects: 63
Study: 11133640

Group type: EXPERIMENTAL
Intervention: Meperidine (25 mg IV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clonidine (0.15 mg IV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Urapidil (25 mg IV)
Number of subjects: 60
Study: 9643276

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg t.i.d.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7881026

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 79

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 79
Study: 3144541

Group type: EXPERIMENTAL
Intervention: Fleroxacin 600 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amoxycillin 3 g
Number of subjects: 20
Study: 31563358

Group type: EXPERIMENTAL
Intervention: Neurodynamic exercises (EEN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extension-oriented exercises (EE)
Number of subjects: 0
Study: 28606503

Group type: EXPERIMENTAL
Intervention: Expectation manipulation intervention (EXPECT)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Supportive therapy (SUPPORT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard medical care alone (SMC)
Number of subjects: 124
Study: 26165739

Group type: EXPERIMENTAL
Intervention: Sphincterotomy
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Biliary sphincterotomy
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Dual sphincterotomy
Number of subjects: 214
Study: 23412407

Group type: EXPERIMENTAL
Intervention: Minimally invasive lateral approach
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional lateral approach
Number of subjects: 50
Study: 21196758

Group type: EXPERIMENTAL
Intervention: Xiao-Feng-San (XFS)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 18303486

Group type: EXPERIMENTAL
Intervention: 75 mg nebicapone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 150 mg nebicapone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 200 mg entacapone
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16782911

Group type: EXPERIMENTAL
Intervention: RT/PCV (radiotherapy followed by six cycles of standard procarbazine, lomustine, and vincristine chemotherapy)
Number of subjects: 368

Group type: COMPARATOR
Intervention: RT only (59.4 Gy of radiotherapy in 33 fractions)
Number of subjects: 368
Study: 14653888

Group type: EXPERIMENTAL
Intervention: Cetrorelix (3 mg single dose)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Goserelin (single dose depot preparation)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Cetrorelix
Number of subjects: 460

Group type: COMPARATOR
Intervention: Goserelin
Number of subjects: 460
Study: 10995804

Group type: EXPERIMENTAL
Intervention: Mammography plus physical examination
Number of subjects: 39405

Group type: COMPARATOR
Intervention: Physical examination only
Number of subjects: 39405
Study: 9772422

Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal control
Number of subjects: 34
Study: 1356328

Group type: EXPERIMENTAL
Intervention: Class III antiarrhythmics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Class I antiarrhythmics
Number of subjects: 0
Study: 2880811

Group type: EXPERIMENTAL
Intervention: Suanzaorentang (250 mg t.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam (2 mg t.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suanzaorentang (250 mg t.i.d.) and Diazepam (2 mg t.i.d.)
Number of subjects: 0
Study: 30148669

Group type: EXPERIMENTAL
Intervention: Computer-based training program on HIV prevention and PrEP
Number of subjects: 0
Study: 27838140

Group type: EXPERIMENTAL
Intervention: High-force traction at 50% body weight (LT50)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-force traction at 10% body weight (LT10)
Number of subjects: 17
Study: 23819593

Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP) - Transbond Plus SEP, 3M Unitek
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional two-step etch and primer method (CM) - 37% phosphoric acid
Number of subjects: 57
Study: 24041638

Group type: EXPERIMENTAL
Intervention: Assisted head extension during tracheal intubation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Without assisted head extension during tracheal intubation
Number of subjects: 68
Study: 20805528

Group type: EXPERIMENTAL
Intervention: DHA supplementation (100 mg/kg per day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (untreated group)
Number of subjects: 50
Study: 18280726

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) during constant workload exercise (CWLE) tests at 75% Pmax
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) during exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) during maximal exercise (MWLE)
Number of subjects: 18
Study: 16166842

Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonobese patients
Number of subjects: 50
Study: 12711664

Group type: EXPERIMENTAL
Intervention: Swedish version of the Readiness to Change Questionnaire (RTCQ)
Number of subjects: 165
Study: 11186501

Group type: EXPERIMENTAL
Intervention: RCT with 150 patients per group
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: RCT with 400 patients per group
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Moderate-sized RCTs
Number of subjects: 10000
Study: 8866037

Group type: EXPERIMENTAL
Intervention: One 7 day 17 beta-estradiol transdermal delivery system (TDS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two 7 day 17 beta-estradiol transdermal delivery systems (TDSs)
Number of subjects: 24
Study: 1310913

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg daily for 6 months
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg daily for 6 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo after 6 months of active treatment
Number of subjects: 12
Study: 6338722

Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185
Study: 30826761

Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg daily) in combination with isoniazid (H), rifampicin (R), ethambutol (E), and pyrazinamide (Z) for the first 2 months, followed by HRE for 4 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 6-month anti-TB treatment regimen (HRZE) for the first 2 months, followed by HRE for 4 months.
Number of subjects: 0
Study: 28489273

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 5% applied twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-level light therapy (LLLT) using the helmet iGrow® device for 25 minutes 3 days weekly
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of topical minoxidil 5% twice daily and LLLT for 25 minutes 3 days weekly for 4 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study: 25851492

Group type: EXPERIMENTAL
Intervention: Paclitaxel/lobaplatin (TL)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cisplatin/5-fluorouracil (PF)
Number of subjects: 68
Study: 24461320

Group type: EXPERIMENTAL
Intervention: Commercial weight loss program (Weight Watchers)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Limited support from health professionals (Control)
Number of subjects: 169
Study: 22988653

Group type: EXPERIMENTAL
Intervention: clindamycin phosphate 1.2%‐‐benzoyl peroxide (BPO) 2.5% gel
Number of subjects: 21

Group type: COMPARATOR
Intervention: adapalene 0.1%‐‐BPO 2.5% gel
Number of subjects: 21
Study: 18817886

Group type: EXPERIMENTAL
Intervention: Implementation intentions (IIs) during a go no-go task
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard instruction during a go no-go task
Number of subjects: 42

Group type: COMPARATOR
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 42
Study: 18005286

Group type: EXPERIMENTAL
Intervention: 7% hydrogen peroxide (HP) bleaching solution
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 5% hydrogen peroxide (HP) bleaching solution
Number of subjects: 61

Group type: COMPARATOR
Intervention: 10% carbamide peroxide (CP) product
Number of subjects: 61
Study: 15329583

Group type: EXPERIMENTAL
Intervention: Closed-loop control of BIS using isoflurane
Number of subjects: 23

Group type: COMPARATOR
Intervention: Manual control of BIS using isoflurane
Number of subjects: 23
Study: 15627777

Group type: EXPERIMENTAL
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 52

Group type: COMPARATOR
Intervention: Laparotomic Burch colposuspension
Number of subjects: 52
Study: 10354808

Group type: EXPERIMENTAL
Intervention: Full sleep deprivation (no sleep on the night before testing)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (restriction to 4 h sleep before testing)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Alcohol treatment (mean blood alcohol content = 0.07%)
Number of subjects: 64
Study: 7551999

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 1292

Group type: EXPERIMENTAL
Intervention: Abdominoperineal resection with preoperative radiotherapy
Number of subjects: 1292

Group type: EXPERIMENTAL
Intervention: Sphincter-saving procedures
Number of subjects: 1292

Group type: EXPERIMENTAL
Intervention: Anterior resection with preoperative radiotherapy
Number of subjects: 1292

Group type: COMPARATOR
Intervention: Control group (no preoperative radiotherapy)
Number of subjects: 1292
Study: 1685105

Group type: EXPERIMENTAL
Intervention: PBSC + ABMT
Number of subjects: 35

Group type: COMPARATOR
Intervention: ABMT
Number of subjects: 35
Study: 7126401

Group type: EXPERIMENTAL
Intervention: Fasted from bedtime (Group A)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Fed 6 hours before anaesthesia (Group B)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Outpatients (fasted from bedtime)
Number of subjects: 128
Study: 31957838

Group type: EXPERIMENTAL
Intervention: shENO1 (sh1, sh2, sh3)
Number of subjects: 0
Study: 31426808

Group type: EXPERIMENTAL
Intervention: Primary hospital attendance
Number of subjects: 1393

Group type: EXPERIMENTAL
Intervention: Secondary hospital attendance
Number of subjects: 1393

Group type: EXPERIMENTAL
Intervention: Tertiary hospital attendance
Number of subjects: 1393
Study: 30216229

Group type: EXPERIMENTAL
Intervention: Tc-MIBI
Number of subjects: 129

Group type: COMPARATOR
Intervention: Tc-DTPA
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Tc-MDP
Number of subjects: 129
Study: 26782685

Group type: EXPERIMENTAL
Intervention: Baseline kyphosis angle (mean 48°, SD 12)
Number of subjects: 3038

Group type: EXPERIMENTAL
Intervention: Each 10° greater kyphosis before adjusting for prevalent fracture
Number of subjects: 3038

Group type: EXPERIMENTAL
Intervention: Each 10° greater kyphosis after adjusting for prevalent fracture
Number of subjects: 3038
Study: 25180608

Group type: EXPERIMENTAL
Intervention: Patient-driven titration of BIAsp 30
Number of subjects: 0

Group type: COMPARATOR
Intervention: Investigator-driven titration of BIAsp 30
Number of subjects: 0
Study: 22288732

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.2 mg after 6 weeks, 1.8 mg after 12 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 44
Study: 19192221

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg bd
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 17428108

Group type: COMPARATOR
Intervention: Imiquimod
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tazarotene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycoalkaloid (BEC-5) cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate
Number of subjects: 0
Study: 15826235

Group type: EXPERIMENTAL
Intervention: Biomechanical self-motion (treadmill walking)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Physical translation (passive transport)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both biomechanical self-motion and physical translation (walking)
Number of subjects: 8
Study: 12042428

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (7576 microg or 25,000 IU of retinol palmitate daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 10210264

Group type: EXPERIMENTAL
Intervention: NXX-066 20 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 30 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 40 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 50 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 60 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 70 mg BID
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: NXX-066 80 mg BID
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7886648

Group type: EXPERIMENTAL
Intervention: Hayek oscillator at 30 oscillations/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hayek oscillator at 60 oscillations/min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham settings (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hayek oscillator at higher spans of pressure
Number of subjects: 8
Study: 31075759

Group type: EXPERIMENTAL
Intervention: Acyl ghrelin (5 pmol/kg/min)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Acyl ghrelin (1 pmol/kg/min)
Number of subjects: 2
Study: 28526482

Group type: EXPERIMENTAL
Intervention: Visual feedback (60 trials)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Force feedback (60 trials)
Number of subjects: 15
Study: 25153479

Group type: EXPERIMENTAL
Intervention: Levulose containing sweets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sucrose containing sweets
Number of subjects: 20
Study: 23507258

Group type: EXPERIMENTAL
Intervention: rATG 1.5mg/kg/day on days 0-3 (Group 1, n=8)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: rATG 3mg/kg on days 0 and 3 (Group 2, n=9)
Number of subjects: 17
Study: 21486974

Group type: EXPERIMENTAL
Intervention: 4-drug fixed-dose combination (FDC) regimen (rifampicin, isoniazid, pyrazinamide, ethambutol)
Number of subjects: 1585

Group type: COMPARATOR
Intervention: Separate drugs regimen
Number of subjects: 1585

Group type: EXPERIMENTAL
Intervention: 4-drug fixed-dose combination (FDC) regimen
Number of subjects: 1585